Inhaled Corticosteroids in COPD: Determinants of Use and Trends in Patient Persistance with Treatment

Inhaled Corticosteroids in COPD: Determinants of Use and Trends in Patient Persistance with Treatment

METHODS: The determinants of a new treatment with inhaled corticosteroids and secular trends in patient persistence with treatment among chronic obstructive pulmonary disease (COPD) patients were investigated. A cohort of 3768 physician-diagnosed, elderly COPD patients was selected between 1990 and...

Full description

Saved in:

Bibliographic Details
Main Authors:	Lucie Blais, Jean Bourbeau, Odile Dheehy, Jacques LeLorier
Format:	Article
Language:	English
Published:	Wiley 2004-01-01
Series:	Canadian Respiratory Journal
Online Access:	http://dx.doi.org/10.1155/2004/289420
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Minimising inhaled corticosteroids for COPD
by: Benji Heran, et al.
Published: (2024-12-01)

Inhaled Corticosteroids Should Not Be Prescribed to All Chronic Obstructive Pulmonary Disease Patients
by: Jean Bourbeau, et al.
Published: (2003-01-01)

Management of New Symptoms of Dyspepsia in the Elderly in Quebec
by: Jacques LeLorier, et al.
Published: (1997-01-01)

Inhaled corticosteroid dose is associated with Pseudomonas aeruginosa infection in severe COPD
by: Antonio Oliver, et al.
Published: (2021-01-01)

Extracellular vesicles from bronchoalveolar lavage fluid provide insights into the inhaled corticosteroids treatment response in COPD
by: Jiahua Fang, et al.
Published: (2025-07-01)

Overtreatment of COPD with inhaled corticosteroids--implications for safety and costs: cross-sectional observational study.
by: Patrick White, et al.
Published: (2013-01-01)

Inhaled Corticosteroid Exposure and Risk of Cataract in Patients with Asthma and COPD: A Systematic Review and Meta-Analysis
by: Osman Savran, et al.
Published: (2023-01-01)

Current Evidence on the Usefulness of Potential Therapies in the Prevention of COPD Exacerbations: Beyond the Use of Bronchodilator Therapy and Inhaled Corticosteroids
by: Juan Marco Figueira-Gonçalves, et al.
Published: (2025-04-01)

Cost-Effectiveness Analysis of Fosfomycin for Treatment of Uncomplicated Urinary Tract Infections in Ontario
by: Louise Perrault, et al.
Published: (2017-01-01)

Number 5: Inhaled Corticosteroids in Asthma
by: Richard Leigh
Published: (2001-01-01)

Treatment with oral or inhaled bronchodilator without inhaled corticosteroids in bronchial asthma: A dangerous weapon!
by: Shital Patil, et al.
Published: (2023-05-01)

Questionnaire about the risk of growth suppression of inhaled corticosteroids
by: Ole D Wolthers
Published: (2019-09-01)

Epithelial-to-mesenchymal transition is an active process in the large airways of patients with asthma-COPD overlap and partially abrogated by inhaled corticosteroid treatment: a bronchoscopy endobronchial biopsy study
by: Surajit Dey, et al.
Published: (2025-05-01)

Evaluating inhaled corticosteroids' impact on osteoporosis and fracture risk in COPD patients: a real-world evidence-based systematic review and meta-analysis
by: Hsiao-Feng Huang, et al.
Published: (2025-06-01)

Applying the risk of bias tool in a systematic review of combination long-acting beta-agonists and inhaled corticosteroids for persistent asthma.
by: Lisa Hartling, et al.
Published: (2011-02-01)

Cost Effectiveness of ‘On Demand’ Hiv Pre-Exposure Prophylaxis for Non-Injection Drug-Using Men Who Have Sex with Men in Canada
by: Estelle Ouellet, et al.
Published: (2015-01-01)

PHARMACOTHERAPY OF SEVERE ASTHMA IN CHILDREN: A NOTE ON INHALED CORTICOSTEROIDS
by: L.M. Ogorodova, et al.
Published: (2011-12-01)

Oral health status of asthmatic children using inhaled corticosteroids
by: Münevver Doğan, et al.
Published: (2021-02-01)

RESULTS OF THE STUDY OF THE CROUP ETIOLOGY IN CHILDREN AND EVALUATION OF INHALANT CORTICOSTEROID EFFICIENCY
by: G.G. Makhkamova, et al.
Published: (2009-08-01)

Effects of a Short Course of Inhaled Corticosteroids in Noneosinophilic Asthmatic Subjects
by: Catherine Lemière, et al.
Published: (2011-01-01)

Clinical Models to Compare the Safety and Efficacy of Inhaled Corticosteroids in Patients with Asthma
by: Krishnan Parameswaran, et al.
Published: (2003-01-01)

Should all patients with COPD be treated with inhaled triple therapy?
by: Don D. Sin, et al.
Published: (2025-04-01)

Inhaler sustainability in asthma and COPD care: a systematic review
by: Agnieszka Ignatowicz, et al.
Published: (2025-07-01)

Role of Inhaled Steroids in Vascular Airway Remodelling in Asthma and COPD
by: Alfredo Chetta, et al.
Published: (2012-01-01)

Cumulative Dispensing of Oral Corticosteroids Over 12 Months in People with COPD
by: Burge AT, et al.
Published: (2025-01-01)

Step up to triple therapy versus switch to dual bronchodilator therapy in patients with COPD on an inhaled corticosteroid/long-acting β2-agonist: post-hoc analyses of KRONOS
by: Dave Singh, et al.
Published: (2025-05-01)

Inhaled corticosteroid effects both eosinophilic and non-eosinophilic inflammation in asthmatic patients
by: Ilknur Basyigit, et al.
Published: (2004-01-01)

Impact of Inhaled Corticosteroids on Growth in Children with Asthma: Systematic Review and Meta-Analysis.
by: Yoon Kong Loke, et al.
Published: (2015-01-01)

Pediatric Perioral Dermatitis Associated with Inhaled Corticosteroids: A Retrospective Case Series
by: Tullio Brunetti, et al.
Published: (2025-04-01)

Pharmacoeconomics of Antibiotic Therapy
by: Jacques Le Lorier
Published: (1994-01-01)

Use and persistence of single and multiple inhaler triple therapy prescribed for patients with COPD in France: a retrospective study on THIN database (OPTI study)
by: Gaëtan Deslee, et al.
Published: (2023-07-01)

Cost-Effectiveness of Single-Inhaler Versus Multiple-Inhaler Triple Therapy in COPD: A German Healthcare Perspective
by: Beeh KM, et al.
Published: (2025-06-01)

Inhaled corticosteroid treatment and pneumonia in patients with chronic obstructive pulmonary disease – nationwide development from 1998 to 2018
by: Allan Klitgaard, et al.
Published: (2024-12-01)

Evaluation of posterior segment changes in pediatric asthma patients with and without inhaled corticosteroid therapy
by: Ulviye Kıvrak, et al.
Published: (2025-08-01)

Elevated Fracture Risks in Patients Using Inhaled Corticosteroids: A Korean Nationwide Study
by: Sung Hye Kong, et al.
Published: (2025-02-01)

Pharmacotherapy of chronic obstructive pulmonary disease: Therapeutic considerations with a focus on inhaled corticosteroids
by: Elvis M. Irusen, et al.
Published: (2020-12-01)

Expression of circulating angiotensin‐converting enzyme 2 in children with asthma and the effects of inhaled corticosteroids
by: Xiang Ma, et al.
Published: (2023-07-01)

Spirometric changes in children with asthma exposed to environmental tobacco smoke and treated with inhaled corticosteroids
by: Radić Snežana, et al.
Published: (2019-01-01)

Osteoporosis Awareness in Asthma Patients Using Inhaled Corticosteroids: A Cross-Sectional Study
by: Sevda Cömert, et al.
Published: (2025-06-01)

Efficacy of Inhaled Corticosteroids in Patients with Bronchiectasis without Airway Hyperresponsiveness: A Pilot Study
by: Safia Ahmed, et al.
Published: (2024-11-01)